Marksans Pharma Limited (NSE:MARKSANS)
183.44
-0.26 (-0.14%)
Oct 30, 2025, 3:30 PM IST
Marksans Pharma Employees
Marksans Pharma had 1,840 employees as of March 31, 2025. The number of employees increased by 699 or 61.26% compared to the previous year.
Employees
1,840
Change (1Y)
699
Growth (1Y)
61.26%
Revenue / Employee
14.41M INR
Profits / Employee
1.90M INR
Market Cap
83.13B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1,840 | 699 | 61.26% |
| Mar 31, 2024 | 1,141 | 289 | 33.92% |
| Mar 31, 2023 | 852 | -38 | -4.27% |
| Mar 31, 2022 | 890 | -248 | -21.79% |
| Mar 31, 2021 | 1,138 | -12 | -1.04% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Apollo Hospitals Enterprise | 42,497 |
| Cipla | 30,313 |
| Zydus Lifesciences | 27,917 |
| Aurobindo Pharma | 27,707 |
| Mankind Pharma | 26,978 |
| Alkem Laboratories | 18,785 |
| Glenmark Pharmaceuticals | 15,800 |
Marksans Pharma News
- 15 days ago - Marksans Pharma’s UK subsidiary Relonchem secures MHRA approval for two products - Business Upturn
- 4 weeks ago - Marksans Pharma shares fall over 3.5% after Trump’s 100% tariff announcement on pharma imports - Business Upturn
- 5 weeks ago - Marksans Pharma’s UK Subsidiary Relonchem secures marketing authorization for Moxonidine tablets from UK MHRA - Business Upturn
- 2 months ago - Marksans Pharma’s UK subsidiary Relonchem secures marketing authorization from MHRA for Metformin tablets - Business Upturn
- 2 months ago - Marksans Pharma shares drop 13% as Q1 net profit falls 34.3% YoY to Rs 58.3 crore, revenue down 5% YoY - Business Upturn
- 2 months ago - Marksans Pharma subsidiary gets USFDA final approval for 20 mg Omeprazole Delayed-Release Tablets - Business Upturn
- 4 months ago - Marksans Pharma receives EIR from USFDA for Time-Cap Labs facility - Business Upturn
- 4 months ago - Marksans Pharma’s UK subsidiary secures approval for Oxybutynin Hydrochloride oral solution - Business Upturn